Department of Immunology, Hospital Ramón y Cajal, Madrid, Spain.
Clin Immunol. 2010 Oct;137(1):51-9. doi: 10.1016/j.clim.2010.06.007.
We described previously that multiple sclerosis (MS) patients with oligoclonal IgM against myelin lipids (M+) develop an aggressive disease. Our aim was to assess possible mechanisms regulating the production of these antibodies. We studied B cell subsets in 180 patients with MS, and 69 with other neurological diseases. M+ MS patients showed a moderate increase of CD5(+) B-cell percentage in peripheral blood and a considerable augment of these cells in cerebrospinal fluid (CSF) that correlated with intrathecal IgM production. The appearance of CD5(+) B cells into the central nervous system (CNS) was related to increased CXCL13 and TNF-alpha levels in CSF. Moreover, the presence of oligoclonal IgM associated with a SNP at position -376 of the TNF-alpha promoter. These results help to elucidate the B lymphocytes responsible for intrathecal IgM secretion in MS and the origin of this abnormal B-cell response in patients with aggressive MS.
我们曾描述过,患有髓鞘脂质寡克隆 IgM(M+)的多发性硬化症(MS)患者会发展为侵袭性疾病。我们旨在评估可能调节这些抗体产生的机制。我们研究了 180 例 MS 患者和 69 例其他神经系统疾病患者的 B 细胞亚群。M+ MS 患者在外周血中显示出 CD5+ B 细胞百分比的适度增加,并且这些细胞在脑脊液(CSF)中显著增加,与鞘内 IgM 产生相关。CD5+ B 细胞出现在中枢神经系统(CNS)与 CSF 中 CXCL13 和 TNF-α水平的升高有关。此外,TNF-α启动子位置-376 的 SNP 与寡克隆 IgM 的存在相关。这些结果有助于阐明 MS 中鞘内 IgM 分泌的 B 淋巴细胞以及侵袭性 MS 患者这种异常 B 细胞反应的起源。